default author photo

Ze-Hao Wang

Fudan University

SCHOLARLY PAPERS

1

DOWNLOADS

121

TOTAL CITATIONS

1

Scholarly Papers (1)

Neoadjuvant Anthracycline Followed by Toripalimab Combined with Nab-Paclitaxel in Patients with Early Triple-Negative Breast Cancer (NeoTENNIS): A Single-Arm, Phase II Study

Number of pages: 31 Posted: 04 Jan 2024
Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University - Shanghai Cancer Center (FUSCC), Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University and Fudan University - Department of Breast Surgery
Downloads 64 (938,792)
Citation 1

Abstract:

Loading...

triple-negative breast cancer, neoadjuvant therapy, immune checkpoint inhibitor, induction treatment, de-escalation

Neoadjuvant Anthracycline Followed by Toripalimab Combined with Nab-Paclitaxel in Patients with Early Triple-Negative Breast Cancer (NeoTENNIS): A Single-Arm, Phase II Study

Number of pages: 49 Posted: 19 Apr 2024
Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University - Shanghai Cancer Center (FUSCC), Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University - Department of Oncology, Fudan University, Fudan University - Department of Breast Surgery, Fudan University - Department of Breast Surgery, Fudan University - Department of Breast Surgery, Fudan University, Fudan University - Department of Breast Surgery and Fudan University - Department of Breast Surgery
Downloads 57 (1,017,159)

Abstract:

Loading...

Triple-negative breast cancer, Neoadjuvant therapy, Immune checkpoint inhibitor, Induction treatment, De-escalation